Acquired inhibitors

Bailliere's Clinical Haematology

Volumn 9, Issue 2, 1996, Pages 331-354

  Cohen, A J ^a   Kessler, C M ^a  

^a ST MICHAEL S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 6; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DESMOPRESSIN ACETATE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; PREDNISONE; PROTHROMBIN; PROTHROMBIN COMPLEX; RECOMBINANT ALPHA INTERFERON; TACROLIMUS; VINCRISTINE; VON WILLEBRAND FACTOR;

BLOOD CLOTTING DISORDER; HEALTH CARE COST; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW;

EID: 0029969926     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(96)80067-9     Document Type: Article

References (100)

1. Austen DEG Lechner K Rizza CR Rhymes IL A comparison of the Bethesda and new Oxford methods of factor VIII antibody assay Thrombosis and Haemostasis 47 1982 72 75
2. Ball J Malia G Greaves M Preston Fe Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor British Journal of Haematology 65 1986 95 100
3. Bänninger H Hardegger T Tobler A Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V British Journal of Haematology 85 1993 528 532
4. Biggs R Austen DEG Denson KWE The mode of action of antibodies which destroy factor VIII. Antibodies which give complex concentration graphs British Journal of Haematology 23 1972 137 155
5. Blatt PM White GC II McMillan CW Roberts HR Treatment of antifactor VIII antibodies Thrombosis and Haemostasis 38 1977 514 523
6. Bracey AW Wu AH Aceves J Platelet dysfunction associated with Wilms' tumor and hyaluronic acid American Journal of Hematology 24 1987 247 257
7. Budde U Dent JA Berkowitz SD Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome Blood 68 1986 1213 1217
8. Campbell E Saral S Mattson J Factor VII inhibitor American Journal of Medicine 68 1980 962 964
9. Castaldi PA Penny R A macroglobulin with inhibitory activity against coagulation factor VIII Blood 35 1970 370 376
10. Castaman G Tosetto A Rodeghiero F Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to Desmopressin and factor VIII concentrate American Journal of Hematology 41 1992 132 136
11. Castaman G Lattavda A Mannucci PM Rogeghiero F Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor American Journal of Hematology 49 1995 83 86
12. Castenskiold EC Coluin BT Kelsey SM Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy in a patient with haemophilia A British Journal of Haematology 87 1994 434 436
13. Castro O Farber LR Clyne LP Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus Annals of Internal Medicine 77 1972 543 548
14. Chavin SI Siegel DM Roccota Jr Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor American Journal of Medicine 85 1988 245 249
15. Chediak J Ashenhurst JB Garlick I Desser RK Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions Blood 56 1980 835 841
16. Chediak J Madej-Zevin P Ratnoff OD Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostate British Journal of Hematology 63 1986 123 133
17. Coller BS Hultin MB Hoyer LW Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis Blood 58 1981 619 624
18. Coppes MJ Zansport SW Sparling CR Acquired von Willebrand disease in Wilms' tumor patients Journal of Clinical Oncology 10 1992 422 427
19. Dalton RG Dewar MS Savidge GF Hypothyroidism as a cause of acquired von Willebrand's disease Lancet i 1987 1007 1009
20. Daly HM Carson PJ Smith JK Intracerebral haemorrhage due to acquired factor XIII inhibitor—successful response to factor XIII concentrate Blood, Coagulation and Fibrinolysis 2 1991 507 514
21. De La Fuente B Panek S Hoyer LW The effect of 1-deamino-8- d -arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitor British Journal of Haematology 59 1985 127 131
22. Delmer A Horellou M Andrew G Life-threatening intracranial bleeding associated with presence of an antifactor VII autoantibody Blood 74 1989 229 232
23. Facon T Caron C Courtin P Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma British Journal of Haematology 80 1992 488 494
24. 1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor Journal of Biological Chemistry 263 1988 5230 5234
25. 2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine Blood 75 1990 1999 2004
26. Francesconi M Korniger C Thaler E Plasmapheresis: its value in the management of patients with antibodies to factor VIII Haemostasis 11 1982 79 86
27. Fukui H Fujimura Y Takahashi Y Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor Thrombosis Research 22 1981 177 184
28. Fulcher CA Mahoney SDG Roberts JR Localization of human factor VIII inhibitor epitopes to two polypeptide fragments Proceedings of the National Academy of Sciences of the USA 82 1985 7728 7732
29. Gan TE Sauers RJ Koutts J Pathogenesis of antibody-induced acquired von Willebrand syndrome American Journal of Hematology 9 1980 363 371
30. Gatti L Mannucci PM Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies Thrombosis and Haemostasis 51 1984 379 384
31. Glueck HI Hong R A circulating anticoagulant in γ1 A multiple myeloma: its modification by penicillin Journal of Clinical Investigation 44 1965 1866 1881
32. Goodrick MJ Prentice AG Copplestone JA Acquired factor XI inhibitor in chronic lymphocytic leukemia Journal of Clinical Pathology 45 1992 352 353
33. Green D Suppression of an antibody to factor VIII by combination of factor VIII and cyclophosphamides Blood 37 1971 381 387
34. Green D Lechner K A survey of 215 non-hemophilic patients with inhibitors to factor VIII Thrombosis and Haemostasis 45 1981 200 203
35. Green D Rademaker AW Briet E A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies Thrombosis and Haemostasis 70 1993 753 757
36. Gringeri A Santagostino E Tradati F Adverse effects of treatment with porcine factor VIII Thrombosis and Haemostasis 65 1991 245 247
37. Hauser I Gisslinger H Locker G Postpartum factor VIII inhibitors Wiener Klinische Wochenschrift 105 1993 355 358
38. Hauser I Schneider B Lechner K Postpartum factor VIII inhibitors Thrombosis and Haemostasis 73 1995 1 5
39. Hay CRM Laurian Y Verroust F Induction of immune-tolerance in patients with haemophilia A and inhibitors treated with porcine FVIII:C by home therapy Blood 76 1990 882 886
40. Hedner U Factor VIIa in the treatment of haemophilia Blood Coagulation and Fibrinolysis 1 1990 307 317
41. Hedner U Schulman S Alberts KA Successful use of rFVIIa in a patient with severe hemophilia A subjected to synovectomy Lancet ii 1988 1193
42. Hedner U Ljungberg J Lund-Hansen T Comparison of the effect of plasma-derived and recombinant human rFVIIa in vitro and in a rabbit model Blood Coagulation and Fibrinolsis 1 1990 145 151
43. Herbst KD Rapaport SI Kenoyer DG Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone Annals of Internal Medicine 95 1981 575 578
44. Hoyer LW Scandella D Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients Seminars in Hematology 31 supplement 4 1994 1 5
45. Israel SJ Israels ED Development of antibodies to bovine and human factor V in two children after exposure to topical bovine thrombin American Journal of Pediatric Hematology/Oncology 16 1994 249 254
46. Jakway JL Acquired von Willebrand's Disease Hematology/Oncology Clinics of North America 6 1992 1409 1419
47. Kasper CK Thromboembolic complications Thrombosis et Diathesis Haemorrhagia 33 1975 640 644
48. Kasper CK The therapy of factor VIII inhibitors Progress in Hemostasis and Thrombosis 9 1989 57 86
49. Kasper CK Aledort LM Counts RB A more uniform measurement of factor VIII inhibitors Thrombosis et Diathesis Haemorrhagia 34 1975 869 871
50. Kernoff PBA Porcine factor VIII: Preparation and use in treatment of inhibitor patients Progress in Clinical and Biological Research 150 1984 207 224
51. Kessler CM Ludlam CA The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate Seminars in Hematology 30 1993 22 27
52. La Spada AR Skålieegg BS Henderson R Brief report: fatal hemorrhage in a patient with an acquired inhibitor of human thrombin New England Journal of Medicine 333 1995 494 497
53. Largo R von Felton A Straub PW Acquired factor IX inhibitor in a nonhaemophilic patient with autoimmune disease British Journal of Haematology 26 1974 129 140
54. Lazarchick J Ashby MA Lazarchick JJ Mechanism of factor VIII inactivation by human antibodies. IV antibody binding prevents factor VIII proteolysis by thrombin Annals of Clinical Laboratory Science 16 1986 497 501
55. Lian ELY Larcada AF Chiu AYZ Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor Annals of Internal Medicine 110 1989 774 778
56. Littlewood JD Bevan SA Kemball-Cook G Evan RJ Variable inactivation of human factor VIII from different sources by human factor VIII inhibitors British Journal of Haematology 77 1991 535 538
57. Lopez-Fernandez MF Lopez Beyes C Martin R Abnormal structure of von Willebrand factor in myeloproliferative syndrome is associated to either thrombotic or bleeding diathesis Thrombosis and Haemostasis 58 1987 753 757
58. Lottenberg R Kentro TB Kitchens CS Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy Archives of Internal Medicine 147 1987 1077 1081
59. Lozier JN Santagostino E Kasparck Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors Seminars in Hematology 30 supplement 1993 10 21
60. Ludlam CA Morrison AE Kessler C Treatment of acquired hemophilia Seminars in Hematology 31 1994 16 19
61. Lusher JM Thrombogenicity associated with factor IX complex concentrate Seminars in Hematology 28 supplement 6 1991 3 5
62. Lusher JM Blatt PM Penner JA Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthrosis in hemophiliacs with inhibitors to factor VIII Blood 62 1983 1135 1138
63. Macik BG Treatment of factor VIII inhibitors: products and strategies Seminars in Thrombosis and Haemostasis 18 1993 13 22
64. Macik BG Gabriel DA White GC II The use of high dose intravenous gammaglobulin in acquired von Willebrand syndrome Archives of Pathology and Laboratory Medicine 112 1988 143 146
65. McKelvey EM Kwaan HC An IgM circulating anticoagulant with factor VIII inhibitory activity Annals of Internal Medicine 77 1972 571 575
66. McMillan CW Shapiro SS Whitehurst D The natural history of factor VIII:C inhibitors in patients with hemophilia A: a National Cooperative Study. II. Observations on the initial development of factor VIII:C inhibitors Blood 71 1988 344 348
67. Mannucci PM Lombardi R Bader R Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies Blood 64 1984 614 621
68. Mateo J Martino R Borrell M Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia Annals of Hematology 67 1993 309 311
69. Miller K Neely JE Krivit W Edson JR Spontaneously acquired factor IX inhibitor in a nonhemophiliac child Journal of Pediatrics 93 1978 232 234
70. Mohri H Acquired von Willebrand Disease in patients with polycythemia rubra vera American Journal of Hematology 26 1987 135 146
71. Morrison AE Ludlam CA Kessler C Use of porcine factor VIII in the treatment of patients with acquired hemophilia Blood 81 1993 1513 1520
72. Nakamura S Kato A Sakata Y Aoki N Bleeding tendency caused by IgG inhibitor to factor XIII treated successfully by cyclophosphamide British Journal of Haematology 68 1988 313 319
73. Nilsson IM Johnson S Sundquist SB A procedure for removing high titer antibodies by extracorporeal protein-A—sepharose adsorption in hemophilia: substitution therapy and surgery in a patient with hemophilia B and antibodies Blood 58 1981 38 44
74. Özsoylu S Özer FL Acquired factor IX deficiency Acta Haematologica 50 1973 305 314
75. Pfliegler G Boda Z Harsfalvi J Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor Postgraduate Medical Journal 65 1989 400 402
76. Rao LVM Zivelin A Iturbe I Rapaport SI Antibody-induced acute factor X deficiency: clinical manifestations and properties of the antibody Thrombosis and Haemostasis 72 1994 363 371
77. Rizza CR Edgcumbe JOP Pitney UR Child JA The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII) Thrombosis et Diathesis Haemorrhagia 28 1972 120 128
78. Sampson BM Greaves M Malla RG Preston FE Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases British Journal of Haematology 54 1983 233 244
79. Sanchez-Medal L Lisker R Lopez ET Unusual circulating anticoagulant in a patient with systemic lupus erythematosus Acta Haematologica 29 1963 117 122
80. Scandella D Mattingly M de Graaf S Colocalization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization Blood 74 1989 1618 1628
81. 2 Blood 82 1993 1767 1775
82. Schmidt ML Gamerman S Smith HE Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors American Journal of Hematology 47 1994 36 40
83. Schnall SF Duffy TP Clyne LP Acquired factor XI inhibitors in congenitally deficient patients American Journal of Hematology 26 1987 323 328
84. Schwartz RS Gabriel DA Aledort LM A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin Blood 86 1995 797 804
85. Schwerdtfeger R Hintz G Huhn G Successful treatment of a patient with postpartum factor VIII inhibitors with recombinant human interferon α2a American Journal of Hematology 37 1991 190 193
86. Seidler CW Mills LE Flowers MED Sullivan KM Spontaneous factor VIII inhibitor occurring in association with chronic graft vs. host disease American Journal of Hematology 45 1994 240 243
87. (in press). Shaffer LG Phillips MD Successful treatment of high titer acquired factor VIII inhibitors in nonhemophiliacs with oral cyclophosphamide and prednisone Blood 1995
88. Shapiro SS Hultin M Acquired inhibitors to the blood coagulation factors Seminars in Thrombosis and Hemostasis 1 1975 336 385
89. Sherman LA Goldstein MA Sise HS Circulating anticoagulant (antifactor VIII) treated with immunosuppressive drugs Thrombosis et Diathesis Haemorrhagia 21 1969 249 258
90. Sié P Bezeaud A Dupouy D An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme Journal of Clinical Investigation 88 1991 290 296
91. Siegbahn A Feltelius N Norlen BJ Hedner U Treatment of acquired hemophilia due to FVIII:C autoantibodies with recombinant FVIIa and cyclosporine Thrombosis and Haemostasis 73 1995 1424
92. Silberstein LE Abraham J Shattil SJ The efficacy of intensive plasma exchange in acquired von Willebrand's disease Transfusion 27 1987 234 237
93. Slocombe GW Newland AC Colvin MP Colvin BT The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII British Journal of Haematology 47 1981 577 585
94. Soff GA Green D Autoantibody to von Willebrand factor in systemic lupus erythematosus Journal of Laboratory and Clinical Medicine 121 1993 424 430
95. Spero JA Lewis JH Hasiba U Corticosteroid therapy for acquired factor VIII:C inhibitors British Journal of Haematology 48 1981 639 642
96. Stein SF Duncar A Cutter D Disseminated intravascular coagulation (DIC) in a hemophiliac treated with recombinant factor VIIa Blood 76 supplement 1 1990 1743
97. Stricker RB Barlogie B Kiprov DD Acquired factor VIII inhibitor associated with chronic interferon-α therapy Journal of Rheumatology 21 1994 350 352
98. Sultan Y Maisonneuve P Kazatzhkine MD Nydegger VE Antiidiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high dose intravenous gammaglobulin Lancet ii 1984 765 768
99. Verbruggen B Novakova I Wessels H The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability Thrombosis and Haemostasis 73 1995 247 251
100. White G Factor VIII inhibitor assay: quantitative and qualitative assay limitations and development needs Seminars in Hematology 31 1994 6 10